Department of Cardiology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Division of Endocrine and Oncologic Surgery, Department of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Biomolecules. 2022 Jan 15;12(1):137. doi: 10.3390/biom12010137.
Long non-coding RNAs (lncRNAs) have emerged as essential biomolecules with variable diagnostic and/or prognostic utility in several diseases, including coronary artery disease (CAD). We aimed for the first time to investigate the potential association of five angiogenesis-related lncRNAs (PUNISHER, SENCR, MIAT, MALAT1, and GATA6-AS) variants with CAD susceptibility and/or severity. TaqMan Real-Time genotyping for PUNISHER rs12318065A/C, SENCR rs12420823C/T, MIAT rs1061540C/T, MALAT1 rs3200401T/C, and GATA6-AS1 rs73390820A/G were run on the extracted genomic DNA from 100 unrelated patients with stable CAD undergoing diagnostic coronary angiography and from 100 controls. After adjusting covariates, the studied variants showed no association with disease susceptibility; however, MIATT/T genotype was associated with a more severe Gensini score. In contrast, MALAT1T/C heterozygosity was associated with a lower score. The lipid profile, and to a lesser extent smoking status, male sex, weight, hypertension, and MALAT1 (T > C) (negative correlation), explained the variance between patients/control groups via a principal component analysis. Incorporating the principal components into a logistic regression model to predict CAD yielded a 0.92 AUC. In conclusion: MIAT rs1061540 and MALAT1 rs3200401 variants were associated with CAD severity and Gensini score in the present sample of the Egyptian population. Further large multi-center and functional analyses are needed to confirm the results and identify the underlying molecular mechanisms.
长链非编码 RNA(lncRNA)已成为重要的生物分子,在多种疾病中具有可变的诊断和/或预后效用,包括冠状动脉疾病(CAD)。我们首次旨在研究 5 种与血管生成相关的 lncRNA(PUNISHER、SENCR、MIAT、MALAT1 和 GATA6-AS)变体与 CAD 易感性和/或严重程度的潜在关联。TaqMan 实时基因分型用于检测 PUNISHER rs12318065A/C、SENCR rs12420823C/T、MIAT rs1061540C/T、MALAT1 rs3200401T/C 和 GATA6-AS1 rs73390820A/G,从 100 名接受诊断性冠状动脉造影的无关联 CAD 患者和 100 名对照者的提取基因组 DNA 中进行。调整协变量后,研究的变体与疾病易感性无关;然而,MIATT/T 基因型与更严重的 Gensini 评分相关。相反,MALAT1T/C 杂合性与较低的评分相关。血脂谱,在较小程度上还有吸烟状况、男性、体重、高血压和 MALAT1(T>C)(负相关),通过主成分分析解释了患者/对照组之间的差异。将主成分纳入逻辑回归模型以预测 CAD 可获得 0.92 AUC。总之:在本埃及人群样本中,MIAT rs1061540 和 MALAT1 rs3200401 变体与 CAD 严重程度和 Gensini 评分相关。需要进一步的大型多中心和功能分析来确认结果并确定潜在的分子机制。